» Articles » PMID: 31019265

IPSC-derived Homogeneous Populations of Developing Schizophrenia Cortical Interneurons Have Compromised Mitochondrial Function

Abstract

Schizophrenia (SCZ) is a neurodevelopmental disorder. Thus, studying pathogenetic mechanisms underlying SCZ requires studying the development of brain cells. Cortical interneurons (cINs) are consistently observed to be abnormal in SCZ postmortem brains. These abnormalities may explain altered gamma oscillation and cognitive function in patients with SCZ. Of note, currently used antipsychotic drugs ameliorate psychosis, but they are not very effective in reversing cognitive deficits. Characterizing mechanisms of SCZ pathogenesis, especially related to cognitive deficits, may lead to improved treatments. We generated homogeneous populations of developing cINs from 15 healthy control (HC) iPSC lines and 15 SCZ iPSC lines. SCZ cINs, but not SCZ glutamatergic neurons, show dysregulated Oxidative Phosphorylation (OxPhos) related gene expression, accompanied by compromised mitochondrial function. The OxPhos deficit in cINs could be reversed by Alpha Lipoic Acid/Acetyl-L-Carnitine (ALA/ALC) but not by other chemicals previously identified as increasing mitochondrial function. The restoration of mitochondrial function by ALA/ALC was accompanied by a reversal of arborization deficits in SCZ cINs. OxPhos abnormality, even in the absence of any circuit environment with other neuronal subtypes, appears to be an intrinsic deficit in SCZ cINs.

Citing Articles

In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline.

Pereira M, Shyti R, Testa G Stem Cell Reports. 2024; 19(6):767-795.

PMID: 38865969 PMC: 11390705. DOI: 10.1016/j.stemcr.2024.05.004.


Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia.

Spathopoulou A, Sauerwein G, Marteau V, Podlesnic M, Lindlbauer T, Kipura T Mol Psychiatry. 2024; 29(10):3128-3140.

PMID: 38684795 PMC: 11449784. DOI: 10.1038/s41380-024-02568-8.


Microglia-neuron interactions in schizophrenia.

Hartmann S, Heider J, Wust R, Fallgatter A, Volkmer H Front Cell Neurosci. 2024; 18:1345349.

PMID: 38510107 PMC: 10950997. DOI: 10.3389/fncel.2024.1345349.


Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.

Perrottelli A, Marzocchi F, Caporusso E, Giordano G, Giuliani L, Melillo A J Psychiatry Neurosci. 2024; 49(2):E109-E125.

PMID: 38490647 PMC: 10950363. DOI: 10.1503/jpn.230112.


Parvalbumin interneuron deficits in schizophrenia.

Marin O Eur Neuropsychopharmacol. 2024; 82:44-52.

PMID: 38490084 PMC: 11413553. DOI: 10.1016/j.euroneuro.2024.02.010.


References
1.
Rapoport J, Giedd J, Gogtay N . Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012; 17(12):1228-38. PMC: 3504171. DOI: 10.1038/mp.2012.23. View

2.
Weinberger D . Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987; 44(7):660-9. DOI: 10.1001/archpsyc.1987.01800190080012. View

3.
Harrison P . Postmortem studies in schizophrenia. Dialogues Clin Neurosci. 2011; 2(4):349-57. PMC: 3181616. View

4.
Jaffe A . Postmortem human brain genomics in neuropsychiatric disorders--how far can we go?. Curr Opin Neurobiol. 2015; 36:107-11. PMC: 4857188. DOI: 10.1016/j.conb.2015.11.002. View

5.
Gonzalez-Burgos G, Cho R, Lewis D . Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry. 2015; 77(12):1031-40. PMC: 4444373. DOI: 10.1016/j.biopsych.2015.03.010. View